WFRF:(Thunell Lena)
Sökning: WFRF:(Thunell Lena) > ErbB receptor tyros...
- Djerf, EmelieLinköpings universitet,Onkologi,Hälsouniversitetet (författare)
ErbB receptor tyrosine kinases contribute to proliferation of malignant melanoma cells : inhibition by gefitinib (ZD1839)
- Artikel/kapitelEngelska2009
Förlag, utgivningsår, omfång ...
- 2009
- printrdacarrier
Nummerbeteckningar
- LIBRIS-ID:oai:DiVA.org:liu-19129
- https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-19129URI
- https://doi.org/10.1097/CMR.0b013e32832c6339DOI
Kompletterande språkuppgifter
- Språk:engelska
- Sammanfattning på:engelska
Ingår i deldatabas
- SwePubSwePub
Klassifikation
Anmärkningar
- Members of the epidermal growth factor (EGF) family of structurally related tyrosine kinase receptors, known as the ErbB receptors (EGFR/ErbB1/HER1, ErbB2/HER2/neu, ErbB3/HER3 and ErbB4/HER4) and their respective ligands, have been suggested to be involved in the development and progression of malignant melanoma. Here we investigate the effects of the ErbB1 tyrosine kinase inhibitor gefitinib (ZD1839, Iressa) on human malignant melanoma cells (RaH3 and RaH5) in vitro. ZD1839 inhibited proliferation of exponentially growing RaH3 and RaH5 cells in a dose-dependent manner with a half-maximally effective dose of 3.5 and 2.0 mu mol/l, respectively. Cell growth was inhibited at 0.1 mu mol/l ZD1839 in both cell lines. Maximal inhibition was accomplished at 10 mu mol/l ZD1839; however, the effect was not complete as both cell lines showed a continuous slow growth during the treatment period. Flow cytometry analysis of cell-cycle distribution showed that ZD1839 treatment caused accumulation of RaH3 and RaH5 cells in the G, phase. The growth arrest induced by ZD1839 coincided with upregulation of the cyclin-dependent kinase inhibitor p27(KIP1). There was no increase in apoptosis as determined by analysis of plasma phosphatidyl serine redistribution. Western blot analysis revealed that ZD1839 substantially reduced tyrosine phosphorylation of ErbB1 as well as ErbB2 and ErbB3. This was accompanied by a concomitant decrease in Akt-phosphorylation, Erk1/2-phosphorylation, and Stat3-phosphorylation. Our results show that ZD1839 interferes with the growth of human malignant melanoma cells by cytostatic effects. These findings indicate the possible use of ErbB receptor kinase inhibitors as a novel treatment strategy in malignant melanoma.
Ämnesord och genrebeteckningar
- antiproliferative
- ErbB receptors
- gefitinib
- melanoma
- tyrosine kinase inhibitor
- MEDICINE
- MEDICIN
Biuppslag (personer, institutioner, konferenser, titlar ...)
- Trinks, CeciliaLinköpings universitet,Onkologi,Hälsouniversitetet(Swepub:liu)cectr74 (författare)
- Abdiu, AvniÖstergötlands Läns Landsting,Linköpings universitet,Kirurgi,Hälsouniversitetet,Hand- och plastikkirurgiska kliniken US (författare)
- Thunell, LenaLinköpings universitet,Cellbiologi,Hälsouniversitetet(Swepub:liu)lenek59 (författare)
- Hallbeck, Anna-LottaÖstergötlands Läns Landsting,Linköpings universitet,Onkologi,Hälsouniversitetet,Onkologiska kliniken US(Swepub:liu)annha32 (författare)
- Walz, Thomas MÖstergötlands Läns Landsting,Linköpings universitet,Onkologi,Hälsouniversitetet,Onkologiska kliniken US(Swepub:liu)thowa08 (författare)
- Linköpings universitetOnkologi (creator_code:org_t)
Sammanhörande titlar
- Ingår i:Melanoma research19:3, s. 156-1660960-89311473-5636
Internetlänk
Hitta mer i SwePub
- Av författaren/redakt...
- Djerf, Emelie
- Trinks, Cecilia
- Abdiu, Avni
- Thunell, Lena
- Hallbeck, Anna-L ...
- Walz, Thomas M
- Artiklar i publikationen
- Melanoma researc ...
- Av lärosätet
- Linköpings universitet
Sök utanför SwePub
- Sök vidare i:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - Nationella bibliotekssystem
- LIBRIS.kb.se
